| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424252100 | Brucella (e.g., Brucella abortus, Brucella canis, etc.) | 6 |
| 20100158954 | Brucella Melitensis Mutants and Methods - Certain attenuated mutants of | 06-24-2010 |
| 20100226942 | Producing an immune response for reducing the risk of developing brucellosis - This document relates to materials and methods for producing an immune response for reducing the risk of developing brucellosis. For example, this document provides vaccines for administration to animals as well as methods for producing an immune response against bacteria that cause brucellosis using vaccines provided herein. The vaccines provided herein can be effective for reducing the risk of developing brucellosis from multiple species of | 09-09-2010 |
| 20110117134 | Gene library of Brucella suis surface antigens - The invention relates to a bacterial antigen library of | 05-19-2011 |
| 20110177127 | Brucella Abortus Proteins and Methods of Use Thereof - Compositions and methods for the diagnosis and prevention of | 07-21-2011 |
| 20120183576 | MODIFIED GRAM-NEGATIVE BACTERIA FOR USE AS VACCINES - The invention relates to Gram-negative bacteria carrying an inactivated gene encoding a glycosyltransferase involved in the synthesis of the core of the LPS of said Gram-negative bacteria, wherein said inactivated gene results in the synthesis of a LPS having a modified core. These strains have an attenuated virulence but induce a humoral immunity sufficient for ensuring vaccination of the host. | 07-19-2012 |
| 20140328880 | Modified Pathogens For Use As Vaccines - Described herein are microorganisms that are modified so that they have an increased ability to be recognized by the innate immune system of a eukaryote, relative to an unmodified microorganism. A microorganism may be a gram-negative bacterium that has been modified to produce high potency lipopolysaccharide, e.g., | 11-06-2014 |
